Department of Psychology, University of California, Los Angles, Los Angeles, CA, USA.
Department of Internal Medicine, Charles R. Drew University, Los Angeles, CA, USA.
Trials. 2022 Feb 3;23(1):109. doi: 10.1186/s13063-022-06023-3.
Cigarette smoking among adults in the USA is a leading cause of preventable death worldwide, even though there has been a decline in prevalence since 2005. The addictive nature of nicotine is the chief reason smokers continue to use tobacco. Although the majority of smokers report a desire to quit smoking, a small minority who attempt to quit achieve long-term cessation. Combined, smoking cessation best practices include coordinated medication and behavioral treatments. However, these treatments are not currently adequately delivered to Medi-Cal beneficiaries in the publicly funded patient-centered medical homes (PCMHs) and community mental health clinics operated by Los Angeles County (LAC)-Department of Health Services (LACDHS) and LAC-Department of Mental Health (LACDMH).
This is a 5-year implementation, cluster-randomized comparative effectiveness trial that will support the implementation of smoking cessation services delivered in LAC-LACDHS-operated outpatient primary care clinics and in LAC-LACDMH-operated community mental health clinics. We will enroll 1000 participants from clinics that will offer smoking cessation services and 200 from clinics that will offer treatment as usual. Participants will be asked to complete assessments at baseline, 3 months, 6 months, and 12 months. The assessments will include self-reports on smoking history, anxiety, stress, quality of life, and participant satisfaction. Participants who are assigned to clinics that provide smoking cessation services will also be asked about the frequency of their participation in the smoking cessation services during the 12-month period.
This study will evaluate the effectiveness and feasibility of implementing smoking cessation services in outpatient primary care and community mental health clinics. It will also determine if there will be higher rates of smoking cessation in the implementation sites as compared to the sites with treatment as usual. If the implementation proves to be effective, the plan is to sustain these services using a workflow we will develop in the LAC-operated sites. This would lead to ameliorating the significant smoking cessation treatment gaps among those served within the LAC Health Agency departments.
ClinicalTrials.gov NCT04717544 "Embedding comprehensive smoking cessation programs into community clinics." Registered on January 22, 2021.
在美国,成年人吸烟是全球可预防死亡的主要原因,尽管自 2005 年以来吸烟率有所下降。尼古丁的成瘾性是吸烟者继续使用烟草的主要原因。尽管大多数吸烟者表示希望戒烟,但少数试图戒烟的人却实现了长期戒烟。综合来看,戒烟的最佳实践包括协调药物和行为治疗。然而,这些治疗方法目前并没有在洛杉矶县(LAC)-卫生服务部(LACDHS)运营的公共资助以患者为中心的医疗之家(PCMH)和社区心理健康诊所以及 LAC-心理健康部(LACDMH)运营的社区心理健康诊所中充分提供给 Medi-Cal 受益人群。
这是一项为期 5 年的实施、集群随机对照效果试验,将支持在 LAC-LACDHS 运营的门诊初级保健诊所和 LAC-LACDMH 运营的社区心理健康诊所中提供戒烟服务。我们将从提供戒烟服务的诊所招募 1000 名参与者和从提供常规治疗的诊所招募 200 名参与者。参与者将被要求在基线、3 个月、6 个月和 12 个月时完成评估。评估将包括吸烟史、焦虑、压力、生活质量和参与者满意度的自我报告。被分配到提供戒烟服务的诊所的参与者还将被问及在 12 个月期间参加戒烟服务的频率。
这项研究将评估在门诊初级保健和社区心理健康诊所中实施戒烟服务的有效性和可行性。它还将确定在实施地点与常规治疗相比,是否会有更高的戒烟率。如果实施证明是有效的,计划是在 LAC 运营的地点使用我们将开发的工作流程来维持这些服务。这将导致改善 LAC 卫生机构部门服务人群中显著的戒烟治疗差距。
ClinicalTrials.gov NCT04717544“将综合戒烟计划嵌入社区诊所”。于 2021 年 1 月 22 日注册。